Nano X Imaging is projected to report a Q2 2026 consensus revenue of $5.38 million and a loss per share of $0.16, with the stock currently trading at approximately $0.83 compared to a median analyst price target of $5.00.
Investors are primarily focused on the company’s liquidity and "going concern" status, as recent filings revealed a decline in cash reserves to $31.4 million, which management warned may not fund operations through 2027.
While the company is expected to deliver 77% year-over-year revenue growth, the market remains wary of the high cash burn rate relative to the commercialization pace of the Nanox.ARC system. Stakeholders are also closely monitoring the AI and software segment, which is forecasted to reach $1.0 million in quarterly revenue following recent integrations.